These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16486034)

  • 1. Chaotic desynchronization of multistrain diseases.
    Schwartz IB; Shaw LB; Cummings DA; Billings L; McCrary M; Burke DS
    Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Dec; 72(6 Pt 2):066201. PubMed ID: 16486034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.
    Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K
    PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using dimension reduction to improve outbreak predictability of multistrain diseases.
    Shaw LB; Billings L; Schwartz IB
    J Math Biol; 2007 Jul; 55(1):1-19. PubMed ID: 17318630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains.
    Kawaguchi I; Sasaki A; Boots M
    Proc Biol Sci; 2003 Nov; 270(1530):2241-7. PubMed ID: 14613610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic effects of antibody-dependent enhancement on the fitness of viruses.
    Cummings DA; Schwartz IB; Billings L; Shaw LB; Burke DS
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15259-64. PubMed ID: 16217017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Arch Virol; 2014 Jan; 159(1):103-16. PubMed ID: 23900750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instabilities in multiserotype disease models with antibody-dependent enhancement.
    Billings L; Schwartz IB; Shaw LB; McCrary M; Burke DS; Cummings DA
    J Theor Biol; 2007 May; 246(1):18-27. PubMed ID: 17270219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinations in disease models with antibody-dependent enhancement.
    Billings L; Fiorillo A; Schwartz IB
    Math Biosci; 2008 Feb; 211(2):265-81. PubMed ID: 17923138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
    Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission.
    Kribs C; Greenhalgh D
    J Math Biol; 2023 Apr; 86(5):85. PubMed ID: 37119296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemics with multistrain interactions: the interplay between cross immunity and antibody-dependent enhancement.
    Bianco S; Shaw LB; Schwartz IB
    Chaos; 2009 Dec; 19(4):043123. PubMed ID: 20059219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement.
    Sun P; Bauza K; Pal S; Liang Z; Wu SJ; Beckett C; Burgess T; Porter K
    Virology; 2011 Dec; 421(2):245-52. PubMed ID: 22033262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.
    Puerta-Guardo H; Mosso C; Medina F; Liprandi F; Ludert JE; del Angel RM
    J Gen Virol; 2010 Feb; 91(Pt 2):394-403. PubMed ID: 19828759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serotype-independent but concentration-dependent enhancing antibodies among Thai dengue patients.
    Teerasut C; Lei HY; Natthakorn K; Jittmittraphap A; Thammapalo S; Witayathawornwong P; Lin YT; Jarman RG; Sawanpanyalert P; Jampangern W; Limkittikul K
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):624-33. PubMed ID: 23077841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of seasonality and import in a minimalistic multi-strain dengue model capturing differences between primary and secondary infections: complex dynamics and its implications for data analysis.
    Aguiar M; Ballesteros S; Kooi BW; Stollenwerk N
    J Theor Biol; 2011 Nov; 289():181-96. PubMed ID: 21907213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.
    Moi ML; Lim CK; Kotaki A; Takasaki T; Kurane I
    J Virol Methods; 2010 Feb; 163(2):205-9. PubMed ID: 19781573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.